During the September 2022 quarter, the world continued to experience persistent inflation. This included the zero tolerance COVID-19 policies in China resulting in the sudden and complete shutdowns of some large cities; the ongoing war in Ukraine; and substantial tightening measures by central banks worldwide.
The Polen Capital Global Growth Fund declined by 2.43 per cent for the September 2022 quarter, trailing the MSCI ACWI Accumulation Index (in AUD) by 2.09 per cent as overweight allocations to the communication services and information technology sectors, zero weightings to the energy, industrials sectors, and an underweight to the financials sectors hindered performance. The depreciating AUD/ USD exchange rate assisted returns by around 6 per cent for the quarter.
Since the inception of the Polen Capital Global Strategy on 31 December 2014, the Portfolio has, in USD, compounded at an annual rate of 8.50 per cent, net of fees, versus 5.68 per cent for the Index, outperforming the Index by 2.82 per cent net of fees.
Contributors and detractors to performance
At an individual company level, the top three absolute contributors were Amazon, ADP, and Autodesk. The three largest absolute detractors were Adobe, ICON, and Adidas. Polen Capital added L’Oréal to the portfolio during the quarter, taking an initial one per cent position and then adding a further one per cent following its compelling earnings report. Share prices can and certainly do wild things in the short run, and Polen Capital believe that over the long term, investee companies will trade for fair valuations. When combined with the earnings growth we expect, the Portfolio is poised to generate attractive client returns over the next three to five years.
Changes in the geopolitical landscape
What changed in the September 2022 quarter relative to the six months prior is the geopolitical landscape, which appears to be even more uncertain with the Ukraine war intensifying, an emerging energy crisis in Europe, and central banks tightening monetary policy further to tackle inflation. Central bank actions this quarter largely began with the U.S. Federal Reserve, which has engaged in its most aggressive campaign to tighten monetary policy since 1981. It instituted a third consecutive 0.75 percentage point increase in interest rates while signalling further raises in the coming months.
The Bank of England responded with its own raise of rates, and Switzerland followed. Central banks in Indonesia, the Philippines, Taiwan, South Africa, and Norway all reacted with rate raises. What does this mean for Global Growth?
The first-order impact of rate increases—increased debt servicing expenses—does not materially impact the investee companies. Polen Capital’s investment guardrails, which have been in place for over three decades, filter out highly leveraged businesses from their investable universe. Most of our companies have more cash than debt, and many have no debt at all. Their fortress balance sheets remove concerns over increased rates leading to increases in debt-related expenses.
The second-order impact of higher rates tends to be an economic slowdown or even a recession. To be clear, Polen Capital are not attempting to predict a slowdown, but we think it may be helpful to share perspective on how our companies tend to perform during these periods. Polen Capital believes most companies in the Index will experience a degradation in their fundamentals. Our companies, on the other hand, tend to separate themselves from lower-quality businesses contained in any Index because they enjoy competitive advantages and benefit from secular tailwinds, allowing growth through cycles. Polen Capital’s aim of mid-teens earnings growth over the next three to five years remains intact regardless of whether a recession occurs or not. Most companies in any Index will not be able to achieve this, based on our experience. Stock returns stem from price and earnings growth, and at the end of the September quarter, the Portfolio’s aggregate P/E multiple is about 21x – at the low end of its range since inception nearly eight years ago. Prices can and certainly do wild things in the short run, and Polen Capital believe that over the long term, our companies will trade for fair valuations. When combined with the earnings growth we expect, we believe the Portfolio is poised to generate attractive client returns over the next three to five years.
Contributors to performance
ADP continues to deliver a solid business performance, with FY22 revenues increasing 10 per cent and adjusted EPS increasing 16 per cent, both above initial guidance. A tight U.S. labour market bodes well for the business into FY23, alongside its ability to earn a portion of its revenues as floating rate income. Amazon reported better-than-expected earnings during the quarter driven by robust earnings and margins in AWS, its cloud division. The company also posted positive numbers for advertising in the face of a tough environment for the sector. Autodesk’s 98 per cent recurring revenue, subscription-based business continues to prove resilient even in the face of a tough macro environment, with its numbers in line with expectations despite China’s Zero-COVID policies and slowing property sector.
Detractors from performance
On the negative side of the coin, late in the quarter, Adobe announced the intent to acquire Figma for $20 billion, financed with half stock and half cash and debt. The market didn’t take kindly to the announcement, and Adobe’s stock fell around 17 per cent on the day. Polen Capital have been owners of Adobe for a long time, respect CEO Shantanu’s vision and ability to execute, and believe management is looking ahead 3-5+ years, as they should be, and making a strategic move. The deal is expensive but reveals that Adobe thinks Figma’s collaboration platform is the way that design development will evolve and that it is more logical to buy than build. It does imply a competitive weakness in this area, but Adobe has a very strong position in digital media creation, which is still a large and growing market. As a natural outcome of capitalism, an extremely profitable and growing market will attract competitors over time. While there are still some questions to be answered and management has some work to do, we believe Adobe still has strong competitive advantages and is likely to be a good investment from here, with or without Figma. With respect to regulation, we’d be surprised if regulators do not at least examine the deal, given Adobe’s position in digital media creation.
If the deal does go through, Polen Capital believe Adobe would invest heavily in supporting and accelerating Figma, bringing Adobe’s vast strength in the photo, video, and editing space to Figma’s platform of real-time collaboration. We think the analogy between Adobe’s solutions being like Microsoft Word and Figma being like Google docs is a pretty good one. There are still plenty of users and uses for Adobe’s existing products (the business is growing nicely), but Figma’s web-based collaboration capabilities, which are a function of designing its platform more like Google Docs, is where some design development work is going. We believe Adobe wants to combine its capabilities with Figma’s platform to accelerate its own evolution and to create new products together. We see the vision. If the acquisition does not go through, as mentioned, web-based collaboration for design development is a big market, it’s growing, and Adobe enjoys a leading position in content creation tools, particularly for more high-value design. This is in addition to its Digital Experience platform, which we view as also highly advantaged and has ample room to grow as well.
While not reflected in the stock price performance, fundamentals remain solid for ICON this year. The integration with PRA Health is progressing nicely, customer retention remains high (it has had no significant customers leave), and employee attrition continues to improve. Despite continued disruption from COVID, weakness in biotech funding, and the ongoing war in Ukraine, top-line growth remains in line with long-term expectations of mid-to-high-single digits. Additionally, ICON continues to expect to reach $10 billion in sales by 2025. Specifically, sales grew 7.8 per cent and 4.4 per cent, respectively, in the March 2022 quarter and the June 2022 quarter, respectively, on a constant currency basis. And, in the June 2022 quarter, sales grew 16 per cent excluding COVID-related studies. Profitability remains stable to slightly improving with gross margins in the high-20 percentile and operating margins in the mid-to-high-teens percentile. The combined company, which benefits from tremendous scale advantages, continues to win new business, and growth in backlog has accelerated (to $20 billion as of the end of the June 2022 quarter).
Adidas continues to suffer from inventory build-up in China, as up to 60 per cent of its stores are in cities that are in some form of lockdown. Despite the rest of the company performing well, China is a significant portion of Adidas’ revenues, which have declined 35 per cent for two quarters running.
An addition to the portfolio
Despite the noise in the market, Polen Capital’s trade activity was especially low during the September 2022 quarter. The team continue to research what we view as deeply attractive businesses trading at more attractive prices than they were at the beginning of the year and believe we already own most of the best companies on offer today. That said, we added L’Oréal to the portfolio during the quarter, taking an initial one per cent position and then adding a further one per cent following its compelling earnings report.
We have been studying globally dominant cosmetics businesses for years, and at a high level, our research revealed that cosmetics and beauty is an extremely durable business. Cosmetics and beauty have been an ingrained part of humanity for at least 10,000 years. Our research led to the purchase of Estée Lauder in 2020, which we sold last year for valuation-related reasons, and now to the addition of L’Oréal to the Portfolio.
L’Oréal was founded in 1909, is headquartered in Paris, France, and is the market leader in the beauty industry with a leading share (more than 14 per cent) and a market capitalisation of more than €180 billion. The company meets and exceeds all guardrails with approximately 30 per cent ROIC (return on invested capital), stable and improving margins, consistent and durable organic growth, and net cash. With A&P (advertising and promotions) and R&D (research and development) of approximately 30 per cent and 3.5 per cent of sales, respectively, the company executes what we see as a successful business model similar to Nike and Adidas.
For decades L’Oréal has acquired and then nurtured brands to globally dominant levels. Today the company has several brands that drive around 75 per cent of company growth (Armani, Garnier, Kiehl’s, Lancôme (more than €4 billion revenue), La Roche Posay, L’Oréal Paris (more than €6 billion), Maybelline, and Yves Saint Laurent. The shifting basis of competition stemming from internet and social media proliferation combined with e-commerce has, in recent years, led to faster and more profitable growth that we believe will continue. Some examples of the shift benefiting L’Oréal is skincare continuing to grow rapidly, where real science and efficacy are involved, and a channel shift from brick-and-mortar to higher margin e-commerce and travel retail. E-commerce was 29 per cent of 2021 revenues, with an equal split among direct-to-consumer, e-retailers, and online pure players.
The company operates four divisions (Professional Products, Consumer Products, L’Oréal Luxe, and Active Cosmetics). Beneficial to the investment case, the divisions with the highest operating margins are the fastest growing and enjoy the strongest secular tailwinds. Further, L’Oréal, which is run as a large portfolio of products, is not reliant on just one variable to drive returns for our clients. In addition to skincare and China, the company is seeing fast growth in North America for its dermatological skincare (where the doctor becomes the salesperson), fragrances, and premium hair care. As long-term shareholders, we also appreciate that management will reinvest most future margin expansion above approximately 35 basis points per year to ensure continued durability.
Polen Capital continue to see nearer-term growth headwinds primarily from COVID-19 grow-over issues. Uncertainty about the trajectory of interest rates and inflation and input costs still weigh on markets and are contributing to a broader ‘risk-off’ sentiment, which is exacerbated by any negative news at a company level. Our long-term earnings growth expectations, however, remain largely unchanged, and we plan to continue to use volatility to take advantage of pricing anomalies and become more concentrated in our best investment ideas for the next five-plus years.
If you would like to learn more about the Polen Capital Global Growth Fund, please visit the fund’s web page to learn more: Polen Capital Global Growth Fund
Past performance is not an indicator of future performance. Returns are not guaranteed and so the value of an investment may rise or fall.
This report has been prepared for the purpose of providing general information, without taking into account your particular objectives, financial circumstances or needs. The issuer of units in the Polen Capital Global Growth Fund (ARSN: 647 518 723) is the Fund’s responsible entity Fundhost Limited (ABN 69 092 517 087) (AFSL: 233045). The Product Disclosure Statement (PDS) contains all of the details of the offer. Copies of the PDS and Target Market Definition (TMD) are available from Montgomery Investment Management, contactable on (02) 8046 5000 or at www.montinvest.com and at https:// fundhost.com.au/ An investment in the Fund must be through a valid paper or online application form accompanying the PDS. Before making any decision to make or hold any investment in the Fund you should consider the PDS and TMD in full. The information provided is general in nature and does not take into account your investment objectives, financial situation or particular needs. You should consider your own investment objectives, financial situation and particular needs before acting upon this information and consider seeking advice from a licensed financial advisor if necessary.You should not base an investment decision simply on past performance. The investment returns of the Fund are not guaranteed, and so the value of an investment may rise or fall.recession covid-19 global growth monetary policy federal reserve lockdown recession interest rates africa europe france ukraine china
UN Initiative Targets And Doxxes Doctors And Nurses Who Don’t Follow COVID-19 Narrative
UN Initiative Targets And Doxxes Doctors And Nurses Who Don’t Follow COVID-19 Narrative
Authored by Katie Spence via The Epoch Times (emphasis…
Authored by Katie Spence via The Epoch Times (emphasis ours),
Nicole Sirotek is a registered nurse in Nevada with over a decade of experience working in some of the harshest conditions. When a hurricane devastated Puerto Rico, Sirotek and the organization she founded, American Frontline Nurses (AFLN), were there and gave out over 500 pounds of medical equipment and supplies.
She hasn’t hesitated to be the first in when an emergency hits and medical professionals are needed. She’s lost count of the number of times she’s woken up on a cot in the middle of nowhere, boots still strapped to her feet, and ready to go.
But in tears during an interview with The Epoch Times, she detailed her ordeal with harassment and doxing over the past year and how she’s contemplated suicide due to crippling anxiety and depression.
“It took such a toll on my mental health. I wasn’t sleeping and wasn’t eating,” Sirotek said.
To regain her mental health, she decided to step back from the group she started. But even that decision brought pain.
“I said after I left New York, I’d do everything that I can to make sure it didn’t happen again,” Sirotek said, recalling the death she witnessed when she volunteered in New York as a nurse at the start of the COVID-19 pandemic. “I mean, for me to step back and take a break just makes me feel like I failed!”
Sirotek is the victim of ongoing harassment. She’s received pictures of her children posed in slaughterhouses and hanging from a noose, drive-by photos of her house, and letters with white powder that exploded upon opening.
The Nevada State Board of Nursing was inundated with calls for Sirotek’s professional demise and flooded with anonymous complaints.
In response, Sirotek filed a police report. Her lawyer sent a cease-and-desist letter. The Epoch Times reviewed the documents.
The reply from the cease-and-desist letter? The client was acting within his First Amendment rights.
The Harassment Begins
In February 2022, Sirotek, as the face of AFLN, a patient advocacy network that boasts 22,000 nurses, appeared before Sen. Ron Johnson (R-Wis.) and testified about the harm patients were experiencing when they sought treatment for COVID-19.
She said she didn’t witness patients dying from the novel virus when she volunteered to work the front lines in New York at the start of the pandemic.
Instead, in her opinion, as a medical professional with multiple master’s degrees, patients were dying from “negligence” and “medical malfeasance.”
Sirotek detailed the withholding by higher-ups of steroids and Ibuprofen and the prescribing of remdesivir. Additionally, there was zero willingness to consider possible early intervention treatments like ivermectin.
As the pandemic continued, such practices only escalated, Sirotek said.
Sirotek’s testimony resulted in cheers, widespread attention, and a target on her back.
“[The harassment] all started the day we got back from DC,” Sirotek said.
At first, the attacks started with the typical “you’re transphobic, you’re anti-LGBTQ. I mean, they even called me racist,” Sirotek, who is Hispanic, recalled.
And as more patients sought AFLN’s help, the attacks increased in frequency and force.
At first, Sirotek said the attacks appeared to come from random people. But as the attacks continued, the terms “Project Halo,” “Team Halo,” and “#TeamHalo” continually cropped up. Especially on TikTok and from two accounts, “@jesss2019” and “@thatsassynp.”
“[@thatsassynp] just kept on saying how I was spreading misinformation, [that] ivermectin doesn’t work,” Sirotek said. “He kept targeting the Nevada State Board of Nursing because I was on the Practice Act Committee, and he did not feel like that was acceptable.”
Craig Perry, a lawyer representing nurses, including Sirotek, before the Nevada State Board of Nursing, confirmed Sirotek’s account. The executive director of the Nevada State Board of Nursing, Cathy Dinauer, declined to provide details on complaints or investigations, stating to The Epoch Times via email that they are “confidential.”
Sirotek said the complaints overwhelmed her ability to defend her nursing license.
“Untimely, they were filing so many complaints against me that [the Nevada State Board of Nursing] had to start filtering them as to what was applicable and not applicable. And [the complaints] just buried my nursing license to the point that we couldn’t even defend it,” Sirotek said.
Attacks Transition to Threats
Whenever Sirotek, or AFLN, tried to set up a community outreach webinar, hateful comments flooded their videos.
Julia McCabe, a registered nurse and the director of advocacy services for AFLN, told The Epoch Times that initially, they tried kicking the trolls out of the outreach videos. But they couldn’t keep up with the overwhelming numbers and had to shut the videos down, usually after only 10 minutes, she said.
To address the swarms, as McCabe labeled them, AFLN started charging an entrance fee for their webinars. But, McCabe said, they’d send out an email with a free access code to all of their subscribers before the webinar started. It helped, but not enough. The swarms kept coming. And the attacks escalated.
On June 5, 2022, @thatsassynp posted a video on TikTok calling for a “serious public uprising,” because the Nevada State Board of Nursing and other regulatory agencies weren’t disciplining nurses for spreading “disinformation.”
It became one of many such videos in the ensuing days. In the comments of one, he stated, “Also, stay tuned as [@jesss2019] will be addressing this as well. We are teaming up (as per usual) to raise awareness and demand action on this issue.” @jesss2019 responded, “Yes!!!! We will get this taken care of.”
Jess and Tyler Kuhk of @thatsassynp have “teamed up” on several occasions, targeting healthcare workers who question the COVID-19 narrative. Team Halo doesn’t officially list Kuhk on its site, but Kuhk posts with the #teamhalo.
In another video, he states, “If you’re new to this series, PLEASE watch the videos in my playlist ‘Nevada board of nursing.’ This started in Feb of this year.” His video has almost 35,000 “loves.”
On June 7, 2022, @jesss2019 posted a video on TikTok accusing Sirotek of spreading misinformation. It included a link to @thatsassynp, and his complaints about Sirotek to the Nevada State Board of Nursing and calls to remove her from the Practice Act Committee. She implored TikTok to boost the message. It, too, became one of many videos attacking Sirotek.
Specifically, @jesss2019 and @thatsassynp took issue with videos and posts from Sirotek, and AFLN, advocating for ivermectin and highlighting possible issues with remdesivir and the COVID-19 vaccines.
@jess2019 removed all of the above videos after The Epoch Times sought comment. The Epoch Times retains copies.
Sirotek says she received the first death threat against herself and her children around the same time, in June 2022.
“They cut off the pictures of my children’s faces from our family photos, where we take them every year on our front porch—we’ve got 11 years of those photos—and they cut them out and put them on the bodies of those little boys that have been sexually abused. And that’s what would get sent to my house. And I gave the police that,” Sirotek said.
In response to a request for comment from The Epoch Times, Sen. Johnson defended Sirotek.
“The COVID Cartel continues to frighten and silence those who tell the truth and challenge their failed response to COVID,” Johnson said. “It is simply wrong for Ms. Sirotek to be smeared and attacked like so many others who have had the courage and compassion to successfully treat COVID patients.”
As the threats continued and escalated, Sirotek also asked Perry to send a cease-and-desist letter to Tyler Kuhk on Aug. 1, 2022.
Kuhk, a nurse practitioner, is the person posting on TikTok under the pseudonym @thatsassynp.
The letter sent to Kuhk alleges that on at least 10 different occasions, @thatsassynp encouraged a “public uprising” against Sirotek. It also details that his videos attacking Sirotek garnered over 400,000 views.
In response, McLetchie Law, a “boutique law firm serving prominent and emerging … media entities” responded to Perry by stating in a letter dated Aug. 16, 2022, “Both Nevada law and the First Amendment provide robust protections for our client’s (and others’) rights to criticize Ms. Sirotek’s dangerous views and practices—and to advocate for her removal from the Nursing Practice Advisory Committee of the Nevada State Board of Nursing.”
It also warned that any attempt to deter Kuhk from his chosen path would “backfire” and could result in a “negative financial impact.” Neither Kuhk nor McLetchie Law responded to The Epoch Times’ request for comment.
Unable to confirm the real name behind the TikTok account @jesss2019, and thus, unable to send her a legal letter, Sirotek posted some of the threats she’d received on Facebook, pleading for @jesss2019 to cease targeting her, and recognize the possible real-world harm.
In desperation, Sirotek asked Perry to file a legal name change, which he did on Sep. 15, 2022, hoping that would thwart people’s ability to look up Sirotek’s information. Perry told The Epoch Times, “Usually, when you do a name change, it’s a public record. But under extenuating circumstances, you can have that sealed.”
In Sirotek’s case, the court recognized the threat to her and her family’s safety, waived the publication requirement, granted the change, and sealed her record on Oct. 4, 2022.
Sirotek, at the behest of Perry, filed a police report detailing the harassment on Oct. 17, 2022.
In December 2022, @jesss2019 posted a video to TikTok doxing Sirotek by revealing her name change. The Epoch Times sought comment from @jesss2019 but has not received a response. After the request for comment, the user removed the video.
Team Halo and Social Media
On Dec. 17, 2020, Theo Bertram, a director at TikTok; Iain Bundred, the head of public policy at YouTube; and Rebecca Stimson, the UK head of public policy for Facebook, appeared before the UK’s House of Commons to explain what their social media sites were doing to combat “anti-vaccination disinformation.”
All three stated their companies employed a “two-pronged approach.” Specifically, “tackle disinformation and promote trusted content.”
Bundred stated that from the beginning of the year to November 2020, YouTube had removed 750,000 videos that promoted “Covid disinformation.”
Stimson stated that between March and October 2020, “12 million pieces of content were removed from [Facebook],” and it had labeled 167 million pieces with a warning.
Bertram stated that for the first six months of 2020, TikTok removed 1,500 accounts for “Covid violation” and had recently increased that activity. “In the last two months, we took action against 1,380 accounts, so you can see the level of action is increasing,” Bertram said.
“In October, we began work with Team Halo,” Bertram added. “I do not know if you are familiar with Team Halo. It is run by the Vaccine Confidence Project at the London School of Hygiene and Tropical Medicine and is about getting reliable, trusted scientists and doctors on to social media to spread trusted information.”
Team Halo’s Origins
On Sep. 20, 2022, Melissa Fleming, the under-secretary-general for global communications at the United Nations, appeared at the World Economic Forum to discuss how the United Nations was “Tackling Disinformation” regarding “health guidance” as well as the “safety and efficacy of the vaccine” for COVID-19.
“A key strategy that we had was to deploy influencers,” Fleming stated. “Influencers who were really keen, who had huge followings, but really keen to help carry messages that were going to serve their communities.”
Fleming also explained that the United Nations knew its messaging wouldn’t resonate as well as influencers, so they developed Team Halo.
“We had another trusted messenger project, which was called Team Halo, where we trained scientists around the world, and some doctors, on TikTok. We had TikTok working with us,” Fleming said. “It was a layered deployment of ideas and tactics.”
Read more here...
Why Is There A COVID Vaccine Mandate For Students?
Why Is There A COVID Vaccine Mandate For Students?
Authored by Margaret Anna Alice via ‘Through The Looking Glass’ Substack,
Letter to the…
Letter to the Stanford Daily: Why Is There a COVID Vaccine Mandate for Students?
“Not to know is bad. Not to wish to know is worse.”
I can’t figure out why Stanford is mandating the COVID vaccine for students.
Is it to protect students from the virus, hospitalization, or death?
Is it to protect them from other students?
Is it to protect the Stanford community members from the students?
If it’s to protect the students from catching COVID, that doesn’t make sense because the CDC says it “no longer differentiate[s] based on a person’s vaccination status because breakthrough infections occur.”
The CDC also acknowledges natural immunity, noting that “persons who have had COVID-19 but are not vaccinated have some degree of protection against severe illness from their previous infection.”
It appears Stanford didn’t get the memo because Maxwell Meyer—a double-jabbed, COVID-recovered alum who was nearly prohibited from graduating for choosing not to get boosted—was informed by an administrator that the booster mandate is “not predicated on history of infection or physical location.”
Despite living 2,000 miles away from campus and not being enrolled in coursework for his final term, Maxwell was told Stanford was “uniformly enforc[ing]” the mandate “regardless of student location.” Does that sound like a rational policy?
Fortunately, a different administrator intervened and granted Maxwell an exemption, but few Stanford students are so lucky. Almost everyone else simply follows the rules without realizing they’ve volunteered for vaccine roulette.
A Cleveland Clinic study of the bivalent vaccines involving 51,011 participants found the risk of getting COVID-19 increased “with the number of vaccine doses previously received”—much to the authors’ surprise.
They were stumped as to why “those who chose not to follow the CDC’s recommendations on remaining updated with COVID-19 vaccination” had a lower risk of catching COVID than “those who received a larger number of prior vaccine doses.”
So if the vaccines don’t keep you from getting COVID, maybe they at least protect you from hospitalization?
That doesn’t wash, either, because according to data from the Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET), hospitalization rates for 18–64-year-olds have increased 11 percent since the vaccine rollout. Worse, kids under 18 have suffered a shocking 74 percent spike in hospitalizations.
An observational study conducted at Germany’s University Hospital Wuerzburg found:
“The rate of adverse reactions for the second booster dose was significantly higher among participants receiving the bivalent 84.6% (95% CI 70.3%–92.8%; 33/39) compared to the monovalent 51.4% (95% CI 35.9–66.6%; 19/37) vaccine (p=0.0028). Also, there was a trend towards an increased rate of inability to work and intake of PRN medication following bivalent vaccination.”
A new paper published in Science titled Class Switch Towards Non-Inflammatory, Spike-Specific IgG4 Antibodies after Repeated SARS-CoV-2 mRNA Vaccination even has Eric Topol concerned:
Late after mRNA Covid vaccines, or with booster or breakthrough infections, there is a shift to IgG4 antibodies, not seen with adenovirus vector vaccines. The clinical significance is not knownhttps://t.co/5thLxRwemm @SciImmunology @UniFAU pic.twitter.com/YozSLVjVLd— Eric Topol (@EricTopol) December 22, 2022
If you don’t know what that means, Dr. Syed Haider spells it out in this tweet. He explains that the shots “train your immune system to ignore the allergen by repeated exposure,” the end result being that “Your immune system is shifted to see the virus as a harmless allergen” and the “virus runs amok.”
Latest IgG4 COVID vax study— Dr. Syed Haider (@DrSyedHaider) December 28, 2022
Think allergy shots. They train your immune system to ignore the allergen by repeated exposure.
That’s what repeated shots with the vax are doing.
Your immune system is shifted to see the virus as a harmless allergen.
Which means: virus runs amok.
Well, then does the vaccine at least prevent people from dying of COVID?
Nope. According to the Washington Post, “Vaccinated people now make up a majority of COVID deaths.”
At Senator Ron Johnson’s December 7, 2022, roundtable discussion on COVID-19 Vaccines, former number-one–ranked Wall Street insurance analyst Josh Stirling reported that, according to UK government data:
“The people in the UK who took the vaccine have a 26% higher mortality rate. The people who are under the age of 50 who took the vaccine now have a 49% higher mortality rate.”
Obtained by a Freedom of Information Act (FOIA) request to KBV (the association representing physicians who receive insurance in Germany), “the most important dataset of the pandemic” shows fatalities starting to spike in 2021.
Data analyst Tom Lausen assessed the ICD-10 disease codes in this dataset, and the findings are startling. His presentation includes the following chart documenting fatalities per quarter from 2016 to 2022:
This parallels the skyrocketing fatality rates seen in VAERS:
The vaccinated are more likely to contract, become hospitalized from, and die of COVID. If the vaccine fails on all of those counts, does it at least prevent its transmission to other students and community members?
The obvious answer is no since we already know it doesn’t prevent you from getting COVID, but this CDC study drives the point home, showing that during a COVID outbreak in Barnstable County, Massachusetts, “three quarters (346; 74%) of cases occurred in fully vaccinated persons.”
Maybe Stanford can tell us why they feel the mandate is necessary. Their booster requirement reads:
“Why does Stanford have a student booster shot requirement? Our booster requirement is intended to support sustained immunity against COVID-19 and is consistent with the advice of county and federal public health leaders. Booster shots enhance immunity, providing additional protection to individuals and reducing the possibility of being hospitalized for COVID. In addition, booster shots prevent infection in many individuals, thereby slowing the spread of the virus. A heavily boosted campus community reduces the possibility of widespread disruptions that could impact the student experience, especially in terms of in-person classes and activities and congregate housing.”
The claim that “booster shots enhance immunity” links to a January 2022 New York Times article. It seems Stanford has failed to keep up with the science because the very source they cite as authoritative is now reporting, “The newer variants, called BQ.1 and BQ.1.1, are spreading quickly, and boosters seem to do little to prevent infections with these viruses.”
Speaking of not keeping up, that same article says the new bivalent boosters target “the original version of the coronavirus and the Omicron variants circulating earlier this year, BA.4 and BA.5.”
It then goes on to quote Head of Beth Israel Deaconess’s Center for Virology & Vaccine Research Dan Barouch, who says, “It’s not likely that any of the vaccines or boosters, no matter how many you get, will provide substantial and sustained protection against acquisition of infection.”
In other words, Stanford’s rationale for requiring the boosters is obsolete according to the authority they cite in their justification.
If Stanford is genuinely concerned about “reduc[ing] the possibility of widespread disruptions that could impact the student experience,” then it should not only stop mandating the vaccine but advise against it.
Some nations have suspended or recommended against COVID shots for younger populations due to the considerable risks of adverse events such as pulmonary embolism and myocarditis—from Denmark (under 50) to Norway (under 45) to Australia (under 50) to the United Kingdom (seasonal boosters for under 50).
The Danish Health Authority explains why people under 50 are “not to be re-vaccinated”:
“People aged under 50 are generally not at particularly higher risk of becoming severely ill from covid-19. In addition, younger people aged under 50 are well protected against becoming severely ill from covid-19, as a very large number of them have already been vaccinated and have previously been infected with covid-19, and there is consequently good immunity among this part of the population.”
Here’s what a Norwegian physician and health official had to say:
“Especially the youngest should consider potential side effects against the benefits of taking this dose.”
—Ingrid Bjerring, Chief Doctor at Lier Municipality
“We did not find sufficient evidence to recommend that this part of the population [younger age bracket] should take a new dose now.… Each vaccine comes with the risk for side effects. Is it then responsible to offer this, when we know that the individual health benefit of a booster likely is low?”
—Are Stuwitz Berg, Department Director at the Norwegian Institute of Public Health
A new Nordic cohort study of 8.9 million participants supports these concerns, finding a nearly nine-fold increase in myocarditis among males aged 12–39 within 28 days of receiving the Moderna COVID-19 booster over those who stopped after two doses.
This mirrors my own findings that myocarditis rates are up 10 times among the vaccinated according to a public healthcare worker survey.
Coauthored by MIT professor and risk management expert Retsef Levi, the Nature article Increased Emergency Cardiovascular Events Among Under-40 Population in Israel During Vaccine Rollout and Third COVID-19 Wave reveals a 25 percent increase in cardiac emergency calls for 16–39-year-olds from January to May 2021 as compared with the previous two years.
The paper cites a study by Israel’s Ministry of Health that “assesses the risk of myocarditis after receiving the 2nd vaccine dose to be between 1 in 3000 to 1 in 6000 in men of age 16–24 and 1 in 120,000 in men under 30.”
A Thai study published in Tropical Medicine and Infectious Disease found cardiovascular manifestations in 29.24 percent of the adolescent cohort—including myopericarditis and tachycardia.
“[W]e need to be upfront that nearly every intervention has some risk, and the coronavirus vaccine is no different. The most significant risk is myocarditis, an inflammation of the heart muscle, which is most common in young men. The CDC cites a rate of 39 myocarditis cases per 1 million second doses given in males 18 to 24. Some studies found a much higher rate; a large Canadian database reported that among men ages 18 to 29 who received the second dose of the Moderna vaccine, the rate of myocarditis was 22 for every 100,000 doses.”
All over the world, prominent physicians, scientists, politicians, and professors are asking pointed questions about illogical mandates; the safety and efficacy of the vaccines; and the dangers posed by the mRNA technology, spike protein, and lipid nanoparticles—including in the UK, Japan, Australia, Europe, and the US.
Formerly pro-vaxx cardiologists such as Dr. Aseem Malhotra, Dr. Dean Patterson, and Dr. Ross Walker are all saying the COVID vaccines should be immediately stopped due to the significant increase in cardiac diseases, adverse events, and excess mortality observed since their rollout, noting that, “until proven otherwise, these vaccines are not safe.”
Dear Prime Minister @RishiSunak,— Dr Aseem Malhotra (@DrAseemMalhotra) December 18, 2022
YOU have the power to stop the ongoing unnecessary harm that is devastating individuals and families. @Keir_Starmer the Labour Party also lost one of its most decorated doctors @KailashChandOBE to this mRNA product. Please stop this roll out NOW https://t.co/SECbfK9joz
BREAKING:— Dr Aseem Malhotra (@DrAseemMalhotra) December 16, 2022
President of the international vascular society raises concerns about covid vaccines in relation to cardiovascular problems.
‘It would be great if someone can show us the light of where to go from here’
We must pause the mRNA jab now to stop more unnecessary harm pic.twitter.com/gIZr19SVl8
And now, perhaps most notably, Dr. John Campbell has performed a 180-degree turn on his previous position and is saying it is time to pause the mass vaccination program “due to the risks associated with the vaccines”:
A Rasmussen poll published on December 7, 2022, found 7 percent of vaccinated respondents have suffered major side effects—a percentage that echoes the 7.7 percent of V-Safe users who sought medical care as well as my own polling data.
Add the 34 percent who reported experiencing minor side effects, and you have nearly 72 million adults who’ve been hit with side effects from the vaccine.
Rasmussen Head Pollster Mark Mitchell explains:
“With 7% having a major side effect, that means over 12 million adults in the US have experienced a self-described major side effect that they attribute to the COVID-19 vaccine. That’s over 11 times the reported COVID death numbers. And also note that anyone who may have died from the vaccine obviously can’t tell us that in the poll.”
“The Pfizer and Moderna trials are both showing a clear signal of increased risk of serious adverse events among the vaccinated.…
“The trial data are indicating that we’re seeing about an elevated risk of these serious adverse events of around 1 in 800 people vaccinated.… That is much, much more common than what you see for other vaccines, where the reported rates are in the range of 1 or 2 per million vaccinees. In these trials, we’re seeing 1 in every 800. And this is a rate that in past years has had vaccines taken off the market.…
“We’re talking about randomized trials … which are widely considered the highest-quality evidence, and we’re talking about the trials that were submitted by Pfizer and Moderna that supported the regulators’ authorization.”
Dr Peter Doshi senior editor of the BMJ wants to know why we haven't already #StoptheShots when 1 in 800 are seriously harmed, yet previous vaccines were suspended for harming 'only' 1 in 100'000.— Porridge2022 (@porridge2022) December 16, 2022
Beats me too! pic.twitter.com/llT4JwL5WQ
And this is the same Pfizer data the FDA tried to keep hidden from the public for 75 years.
Nothing to see here … except 1,223 deaths, 158,000 adverse events, and 1,291 side effects reported in the first 90 days according to the 5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports—and those numbers are likely underreported by a factor of at least 10 (my conservative calculations show an underreporting factor (URF) of 41 for VAERS).
Stanford is asking students to risk a 1 in 800 chance of serious adverse events—meaning the kind of events that can land you in the hospital, disable you, and kill you. And for what?
Anyone who knows how to perform a cost-benefit analysis can see this is all cost and zero benefit.
Stanford’s own Dr. John Ioannidis—professor of medicine, epidemiology & population health, statistics, and biomedical data science—demonstrated that college students are at a near-zero risk of dying from COVID-19 in his “Age-Stratified Infection Fatality Rate of COVID-19 in the Non-Elderly Population.”
One of the six most-cited scientists in the world, Ioannidis found the median IFR was 0.0003 percent for those under 20 and 0.002 percent for twenty-somethings, concluding the fatalities “are lower than pre-pandemic years when only the younger age strata are considered” and that “the IFR in non-elderly individuals was much lower than previously thought.”
And yet Ioannidis’s employer is mandating an experimental product with extensively documented risks of severe harm.
What if a Stanford student dies and the coroner determines it was caused by the vaccine? That happened with George Watts Jr., a 24-year-old college student whose cause of death Chief Deputy Coroner Timothy Cahill Jr. attributed to “COVID-19 vaccine-related myocarditis.” Cahill says, “The vaccine caused the heart to go into failure.”
“We are revoking our vaccination policy and will no longer require students, employees, and visitors to be vaccinated to come to campus.”
The timing is interesting, don’t you think? I’m sure it’s just a coincidence—even though this Clinical Research in Cardiology paper determined vaccine-induced myocardial inflammation was the cause of death in “five persons who have died unexpectedly within seven days following anti-SARS-CoV-2-vaccination.” In that analysis, the authors “establish the histological phenotype of lethal vaccination-associated myocarditis.”
Coincidences notwithstanding, Stanford may want to revoke the mandate before anything like that happens to one of its students … if it hasn’t already.
“Mandating COVID-19 vaccines under an EUA is legally and ethically problematic. The act authorizing the FDA to issue EUAs requires the secretary of the Department of Health and Human Services (HHS) to specify whether individuals may refuse the vaccine and the consequences for refusal. Vaccine mandates are unjustified because an EUA requires less safety and efficacy data than full Biologics License Application (BLA) approval.”
Dr. Naomi Wolf delivered an impassioned speech to her alma mater, Yale, in which she called their booster mandate “a serious crime. It is deeply illegal. Certainly, it violates Title IX.” She explains:
“Title IX commits the university to not discriminate on the basis of sex or gender in getting an equal education.… I oversee a project in which 3,500 experts review the Pfizer documents released under court order by a lawsuit. In that document, there is catastrophic harm to women! And especially to young women! And especially to their reproductive health.… 72% of those with adverse events in the Pfizer documents are women!”
Other universities are currently facing lawsuits for mandating the COVID vaccine in violation of state laws, including one against Ohio University, University of Cincinnati, Bowling Green State University, and Miami University of Ohio.
Abundant evidence proves the vaccines FAIL to:
prevent contraction of COVID
lower hospitalization rates
By the same token, this evidence shows the vaccines are ASSOCIATED with:
heightened transmission levels
greater chances of catching COVID
increased hospitalization rates
higher excess mortality
disproportionate injuries to women
Why is Stanford mandating these unsafe and ineffective products, again?
If logic, peer-reviewed studies, and legal concerns such as the violation of Title IX don’t convince Stanford to rescind the mandate, then what about its stated ethical commitment to upholding its Code of Conduct?
BMJ’s Journal of Medical Ethics recently published COVID-19 Vaccine Boosters for Young Adults: A Risk Benefit Assessment and Ethical Analysis of Mandate Policies at Universities. In this paper, eminent researchers from Harvard, Oxford, Johns Hopkins, and UC San Francisco (among other institutions) present five reasons university mandates are unethical.
They argue that the vaccines:
“(1) are not based on an updated (Omicron era) stratified risk-benefit assessment for this age group; (2) may result in a net harm to healthy young adults; (3) are not proportionate: expected harms are not outweighed by public health benefits given modest and transient effectiveness of vaccines against transmission; (4) violate the reciprocity principle because serious vaccine-related harms are not reliably compensated due to gaps in vaccine injury schemes; and (5) may result in wider social harms.” (emphases mine here and below)
They calculate that:
“To prevent one COVID-19 hospitalisation over a 6-month period, we estimate that 31,207–42,836 young adults aged 18–29 years must receive a third mRNA vaccine.”
The authors conclude that:
“university COVID-19 vaccine mandates are likely to cause net expected harms to young healthy adults—for each hospitalisation averted we estimate approximately 18.5 SAEs and 1,430–4,626 disruptions of daily activities.… these severe infringements of individual liberty and human rights are ethically unjustifiable.”
This builds on a previously published BMJ Global Health article by some of the same authors titled, “The Unintended Consequences of COVID-19 Vaccine Policy: Why Mandates, Passports, and Restrictions May Cause More Harm Than Good.”
In this paper, the authors contend that COVID-19 vaccine mandates “have unintended harmful consequences and may not be ethical, scientifically justified, and effective” and “may prove to be both counterproductive and damaging to public health.”
Over the course of history, countless products once thought to be safe—from DDT to cigarettes to thalidomide for pregnant women to Vioxx—were eventually discovered to be dangerous and even lethal. Responsible governments, agencies, and companies pull those products from the market when the scientific data proves harm—and institutions that care about their community members certainly don’t mandate those products when evidence of risk becomes obvious, as is the case now for the experimental COVID vaccines.
Mahatma Gandhi once stated:
“An error does not become truth by reason of multiplied propagation, nor does truth become error because nobody sees it. Truth stands, even if there be no public support. It is self-sustained.”
The truth is clear to anyone who’s willing to look.
Will it stand up for the lives and health of its students—or will it wait until tragedy strikes another George Watts Jr. or Megha Thakur?
This is a historic opportunity for Stanford to prove its allegiance to people, scientific data, and critical thought over pharmaceutical donors, political pressures, and conformist thinking.
The stakes could not be higher.
* * *
For 16.4 cents/day (annual) or 19.7 cents/day (monthly), you can help Margaret fight tyranny while enjoying access to premium content like Memes by Themes, “rolling” interviews, podcasts, Behind the Scenes, and other bonus content:
Massive Peer-Reviewed Mask Study Shows ‘Little To No Difference’ In Preventing COVID, Flu Infection
Massive Peer-Reviewed Mask Study Shows ‘Little To No Difference’ In Preventing COVID, Flu Infection
A massive international research collaboration…
A massive international research collaboration that analyzed several dozen rigorous studies focusing on "physical interventions" against COVID-19 and influenza found that they provide little to no protection against infection or illness rates.
The study, published in the peer-reviewed Cochrane Database of Systematic Reviews, is the strongest science to date refuting the basis for mask mandates worldwide.
Nearly 60% of South Korea's population has now tested positive for COVID despite nearly three years of consistent universal masking with overwhelming compliance— Ian Miller (@ianmSC) January 25, 2023
When will it be enough for "experts" to admit masks don't work? pic.twitter.com/LS0JF9niog
And of course, the CDC still recommends masking in areas with "high" rates of transmission (fewer than 4% of US counties, as Just the News notes), along with indoor masking in areas with "medium" rates of transmission (27%).
Masks are still required in educational institutions in Democratic strongholds such as New York, New Jersey, Massachusetts, Pennsylvania, Washington and California, according to the Daily Mail. Boston Public Schools denied its "temporary masking protocol" in early January was a "mandate," following a public letter against the policy by student Enrique Abud Evereteze.
South Korea is still requiring masks on public transport and in medical facilities after dropping COVID mandates in most indoor settings, including gyms, Monday, Reuters reported. -Just the News
According to the Cochrane study, which included the work of researchers at institutions in the U.K., Canada, Australia, Italy and Saudi Arabia, a total of 78 studies were analyzed. Most recent additions to the meta-analysis were 11 new randomized controlled trials.
As unlisted study author Carl Heneghan - who directs the Centre for Evidence-Based Medicine at the University of Oxford noted on Twitter: "Wearing masks in the community probably makes little or no difference to the outcome of influenza‐like illness (ILI)/COVID‐19 like illness compared to not wearing masks."
Wearing masks in the community probably makes little or no difference to the outcome of influenza‐like illness (ILI)/COVID‐19 like illness compared to not wearing masks (risk ratio (RR) 0.95, 95% confidence interval (CI) 0.84 to 1.09; 9 trials, 276,917 participants— Carl Heneghan (@carlheneghan) January 30, 2023
Harms were rarely measured and poorly reported (very low‐certainty evidence).— Carl Heneghan (@carlheneghan) January 30, 2023
The Danish study had trouble finding a major journal willing to publish its controversial findings that wearing surgical masks had no statistically significant effect on infection rates, even among those who claimed to wear them "exactly as instructed."
Mainstream media overlooked red flags in the Bangladeshi mask study, which found no effect for surgical masks under age 50 and a difference of only 20 infections between control and treatment groups among 342,000 adults. -JTN
Bottom line, mask wearing "probably makes little to no difference," when it comes to influenza-like or COVID-like illnesses, regardless of type of mask used.
2/ LARGE Cochrane Rev (just published 1/30/23) of RCT data ALSO CONFIRMS NO BENEFIT of N95 masks vs. med/surg masks, in either community (n~8K) or HCW (n~8K) settings for prevention of flu-like illness or lab confirmed flu https://t.co/N4TkgI4uUR pic.twitter.com/0DCdYAPo7x— Andrew Bostom, MD, MS (@andrewbostom) January 31, 2023
We're sure the cult of Fauci will now start insisting peer-reviewed meta-analyses aren't 'the science.'
Why Is There A COVID Vaccine Mandate For Students?
“Markets Are Tense”: Futures Slide As Central Bank Jitters Rise
EY Eyes Comeback for Biopharma M&A
Five Consumer Staples Stocks to Consider as Recession Shields
IMF projects global growth at 2.9%; Disinflation to bring little comfort
Genomic methods aid study of Seattle 2017-2022 Shigella outbreak
Early diagnosis and monitoring of lupus nephritis – on your smartphone
Hedges: Ukraine, The War That Went Wrong
Is Emerging Markets Debt Well Positioned?
Biden To End COVID-19 Emergency Declarations On May 11, Also Ends Title 42 Policy At Border
International6 hours ago
Why Is There A COVID Vaccine Mandate For Students?
Uncategorized12 hours ago
MAA REPORTS FOURTH QUARTER AND FULL YEAR 2022 RESULTS
Spread & Containment11 hours ago
Early diagnosis and monitoring of lupus nephritis – on your smartphone
Uncategorized8 hours ago
Tennessee Population Grows As Residents Leave More Liberal States
Uncategorized13 hours ago
Wonderful companies at wonderful prices?
Uncategorized21 hours ago
Fed Preview: 25bps And Then “The End Is Very Much In Sight”
Uncategorized19 hours ago
Robotic process automation market 2023-2027: A descriptive analysis of five forces model, market dynamics, and segmentation – Technavio
Uncategorized19 hours ago
Robotic cells market: Driven by the increasing industrial automation – Technavio